ARTICLE | Clinical News
Fampridine-SR regulatory update
October 26, 2009 7:00 AM UTC
Acorda said FDA extended the PDUFA date for an NDA for Fampridine-SR to improve walking ability in patients with multiple sclerosis by three months to Jan. 22 from Oct. 22. Acorda said it submitted ad...